223 related articles for article (PubMed ID: 38012308)
1. Engaging natural antibody responses for the treatment of inflammatory bowel disease via phosphorylcholine-presenting nanofibres.
Curvino EJ; Roe EF; Freire Haddad H; Anderson AR; Woodruff ME; Votaw NL; Segura T; Hale LP; Collier JH
Nat Biomed Eng; 2024 May; 8(5):628-649. PubMed ID: 38012308
[TBL] [Abstract][Full Text] [Related]
2. Self-assembled peptide nanofibers raising durable antibody responses against a malaria epitope.
Rudra JS; Mishra S; Chong AS; Mitchell RA; Nardin EH; Nussenzweig V; Collier JH
Biomaterials; 2012 Sep; 33(27):6476-84. PubMed ID: 22695068
[TBL] [Abstract][Full Text] [Related]
3. Phosphorylcholine-tuftsin compound prevents development of dextransulfate-sodium-salt induced murine colitis: implications for the treatment of human inflammatory bowel disease.
Ben-Ami Shor D; Bashi T; Lachnish J; Fridkin M; Bizzaro G; Barshak I; Blank M; Shoenfeld Y
J Autoimmun; 2015 Jan; 56():111-7. PubMed ID: 25479760
[TBL] [Abstract][Full Text] [Related]
4. Identification of IgG1 isotype phosphorylcholine antibodies for the treatment of inflammatory cardiovascular diseases.
de Vries MR; Ewing MM; de Jong RCM; MacArthur MR; Karper JC; Peters EAB; Nordzell M; Karabina SAP; Sexton D; Dahlbom I; Bergman A; Mitchell JR; Frostegård J; Kuiper J; Ninio E; Jukema JW; Pettersson K; Quax PHA
J Intern Med; 2021 Jul; 290(1):141-156. PubMed ID: 33342002
[TBL] [Abstract][Full Text] [Related]
5. Supramolecular Peptide Self-Assemblies Facilitate Oral Immunization.
Curvino EJ; Woodruff ME; Roe EF; Freire Haddad H; Cordero Alvarado P; Collier JH
ACS Biomater Sci Eng; 2024 May; 10(5):3041-3056. PubMed ID: 38623037
[TBL] [Abstract][Full Text] [Related]
6. Peptide mimic of phosphorylcholine, a dominant epitope found on Streptococcus pneumoniae.
Harris SL; Park MK; Nahm MH; Diamond B
Infect Immun; 2000 Oct; 68(10):5778-84. PubMed ID: 10992485
[TBL] [Abstract][Full Text] [Related]
7. Conversion of low antibody responders into high responders by up-regulating the T cell response to a selective epitope.
Mikszta JA; Kim BS
J Immunol; 1996 Oct; 157(7):2883-90. PubMed ID: 8816393
[TBL] [Abstract][Full Text] [Related]
8. Active immunotherapy for C5a-mediated inflammation using adjuvant-free self-assembled peptide nanofibers.
Hainline KM; Haddad HF; Gilpin A; Curvino EJ; Varghese S; Collier JH
Acta Biomater; 2024 Apr; 179():83-94. PubMed ID: 38447809
[TBL] [Abstract][Full Text] [Related]
9. Active immunotherapy for TNF-mediated inflammation using self-assembled peptide nanofibers.
Mora-Solano C; Wen Y; Han H; Chen J; Chong AS; Miller ML; Pompano RR; Collier JH
Biomaterials; 2017 Dec; 149():1-11. PubMed ID: 28982051
[TBL] [Abstract][Full Text] [Related]
10. The PCome of Ascaris suum as a model system for intestinal nematodes: identification of phosphorylcholine-substituted proteins and first characterization of the PC-epitope structures.
Timm T; Grabitzki J; Severcan C; Muratoglu S; Ewald L; Yilmaz Y; Lochnit G
Parasitol Res; 2016 Mar; 115(3):1263-74. PubMed ID: 26728072
[TBL] [Abstract][Full Text] [Related]
11. Biological mimicry of antigenic stimulation: analysis of the in vivo antibody responses induced by monoclonal anti-idiotypic antibodies.
Huang JY; Ward RE; Kohler H
Immunology; 1988 Jan; 63(1):1-8. PubMed ID: 3338815
[TBL] [Abstract][Full Text] [Related]
12. Hapten-induced model of murine inflammatory bowel disease: mucosa immune responses and protection by tolerance.
Elson CO; Beagley KW; Sharmanov AT; Fujihashi K; Kiyono H; Tennyson GS; Cong Y; Black CA; Ridwan BW; McGhee JR
J Immunol; 1996 Sep; 157(5):2174-85. PubMed ID: 8757344
[TBL] [Abstract][Full Text] [Related]
13. PD-L2 Regulates B-1 Cell Antibody Production against Phosphorylcholine through an IL-5-Dependent Mechanism.
McKay JT; Haro MA; Daly CA; Yammani RD; Pang B; Swords WE; Haas KM
J Immunol; 2017 Sep; 199(6):2020-2029. PubMed ID: 28768724
[TBL] [Abstract][Full Text] [Related]
14. Induction of immune response to Streptococcus pneumoniae by administration of oral viridans streptococci via phosphorylcholine determinant.
Miwa Y; Ito HO; Inoue M; Oho T
FEMS Immunol Med Microbiol; 2005 Mar; 43(3):441-8. PubMed ID: 15708320
[TBL] [Abstract][Full Text] [Related]
15. Mucosal immune features to phosphorylcholine by nasal Flt3 ligand cDNA-based vaccination.
Baatarjav T; Kataoka K; Gilbert RS; Terao Y; Fukui M; Goto M; Kawabata S; Yamamoto M; Fujihashi K; Ito HO
Vaccine; 2011 Aug; 29(34):5747-57. PubMed ID: 21683111
[TBL] [Abstract][Full Text] [Related]
16. Passive immunization with monoclonal IgM antibodies against phosphorylcholine reduces accelerated vein graft atherosclerosis in apolipoprotein E-null mice.
Faria-Neto JR; Chyu KY; Li X; Dimayuga PC; Ferreira C; Yano J; Cercek B; Shah PK
Atherosclerosis; 2006 Nov; 189(1):83-90. PubMed ID: 16386745
[TBL] [Abstract][Full Text] [Related]
17. Idiotope antigens (Ab2 alpha and Ab2 beta) can induce in vitro B cell proliferation and antibody production.
Huang JH; Ward RE; Kohler H
J Immunol; 1986 Aug; 137(3):770-6. PubMed ID: 2424981
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylcholine-targeting immunization reduces atherosclerosis.
Caligiuri G; Khallou-Laschet J; Vandaele M; Gaston AT; Delignat S; Mandet C; Kohler HV; Kaveri SV; Nicoletti A
J Am Coll Cardiol; 2007 Aug; 50(6):540-6. PubMed ID: 17678738
[TBL] [Abstract][Full Text] [Related]
19. Production of Epitope-Specific Antibodies by Immunization with Synthetic Epitope Peptide Formulated with CpG-DNA-Liposome Complex Without Carriers.
Kim D; Lee Y; Kwon HJ
Methods Mol Biol; 2015; 1348():127-35. PubMed ID: 26424269
[TBL] [Abstract][Full Text] [Related]
20. Comparative study of α-helical and β-sheet self-assembled peptide nanofiber vaccine platforms: influence of integrated T-cell epitopes.
Wu Y; Kelly SH; Sanchez-Perez L; Sampson JH; Collier JH
Biomater Sci; 2020 Jun; 8(12):3522-3535. PubMed ID: 32452474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
